Physician profile
Luis E Roca
NPI 1255533477
$2,016.98
in general payments reported to CMS, 2019-2025
25 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $33.94 · 2021: $292 · 2022: $488 · 2023: $395 · 2024: $367 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,013.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $353.53 | 2022-2025 | |
| Astellas Pharma US INC | $233.09 | 2022-2024 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $163.11 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Abbvie INC. | $160.90 | 2019-2024 | |
| Medicem INC. | $158.30 | 2021-2022 | |
| Hologic Sales and Service, LLC | $147.80 | 2021-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Tela Bio, INC. | $144.14 | 2022 | |
| Pfizer INC. | $124.07 | 2019-2025 | |
| Exact Sciences Corporation | $62.17 | 2023-2024 | Cologuard Collection Kit |
| Allergan, INC. | $62.17 | 2019-2020 | |
| Therapeuticsmd, INC. | $58.21 | 2019-2021 | |
| Intuitive Surgical, INC. | $45.90 | 2022-2023 | Da Vinci Surgical System |
| Myovant Sciences INC. | $38.62 | 2021 | |
| Innovation Technologies INC | $38.14 | 2024 | Irrisept |
| Bayer Healthcare Pharmaceuticals INC. | $37.75 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $25.59 | 2024 | |
| Millicent US INC | $21.91 | 2025 | Femlyv, Intrarosa |
| Roche Diagnostics Corporation | $20.93 | 2021 | |
| Becton, Dickinson and Company | $19.96 | 2022 | |
| Alydia Health | $19.71 | 2021 | |
| Exeltis, USA INC. | $19.48 | 2023 | Slynd |
| Shield Therapeutics INC | $18.34 | 2024 | |
| Ibsa Pharma INC. | $17.62 | 2023 | Tirosint, Licart |
| Evofem Biosciences, INC. | $17.15 | 2024 | |
| Organon LLC | $8.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Roca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.